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Abstract 
Elevated DNA repair processes represent resistance mechanisms to treatment of 
malignancies with alkylating agents.  Recently, the cell cycle checkpoint abrogator, 
UCN-01, was reported to inhibit nucleotide excision repair in cell free systems.  We 
hypothesized that if UCN-01 was combined with DNA damaging agents, UCN-01 might 
inhibit the damage repair processes, thereby enhancing cytotoxicity in quiescent cells.  
Here, we investigated the effect of UCN-01 on DNA repair and viability of quiescent 
normal lymphocytes and chronic lymphocytic leukemia (CLL) lymphocytes treated with 
ultraviolet (UV) or the cyclophosphamide prodrug 4-hydroperoxycyclophosphamide (4-
HC).  DNA damage repair kinetics were determined as DNA single strand breaks by the 
alkaline single cell gel electrophoresis (comet) assay and by [3H]thymidine incorporation.  
Pre-treatment with UCN-01 inhibited DNA repair initiated by UV or 4-HC in normal 
lymphocytes as well as CLL lymphocytes in a concentration-dependent manner at 
clinically relevant levels (50 nM to 300 nM).  This inhibition was demonstrated by the 
decreases in incision capability, DNA resynthesis, and in re-joining, suggesting that 
UCN-01 inhibits the multiple sites of the repair processes.  The higher UCN-01 
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concentration (300 nM) maximized the inhibitory effects and enhanced the UV- or 4-HC-
induced cytotoxicity as determined by annexin V binding or Hoechst 33342 staining.  
This enhancement was not obtained by the lower concentrations that incompletely 
inhibited the repair, suggesting the close association between the inhibition of the repair 
and the enhancement of the cytotoxicity.  Our findings suggest that UCN-01 may be a 
good candidate for combination strategies of cancer treatment.  
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Introduction 
UCN-01 is a novel anti-cancer agent that was originally identified as a more 
specific inhibitor of protein kinase C than the parent compound staurosporine (1).  UCN-
01 has shown a variety of effects on the cell cycle and antiproliferative activity on 
growing cells (2, 3).  However, the interaction of UCN-01 with protein kinase C is unlikely 
to be responsible for all of these effects on the cell (4, 5).  As a single agent, UCN-01 
blocks cell cycle progression from G1 to S phase and induces G1 accumulation in 
several human tumor cell lines (4, 6).  This accumulation is accompanied by a decrease 
in cyclin-dependent kinase 2 activity.  UCN-01 also induces apoptosis in various tumor 
cell lines such as leukemia (5, 7), colon carcinoma (7), and lung carcinoma (8).  In some 
cases, the induction of apoptosis by UCN-01 is correlated to the activity of cyclin-
dependent kinase 1 and 2 (5, 7).    
In combination treatments, concentrations of UCN-01 that are not cytotoxic has 
been shown to abrogate arrest of the cell cycle in S or G2 following DNA damage by 
gamma radiation or anti-cancer drugs such as mitomycin C, cisplatin, camptothecin, 5-
fluorouracil, and nucleoside analogues (9 - 14).  Such abrogation of the G2 checkpoint is 
 - 6 - 
associated with the inhibition of the DNA damage checkpoint kinase, Chk1 (15), and is 
related to increased cytotoxicity.  Thus, because of these unique dysreguratory effects 
on the cell cycle in growing cells, UCN-01 is now known as a cell cycle checkpoint 
abrogator, and its activity is being evaluated both as a single agent and in combinations 
(2, 3, 16).  
Recently, UCN-01 was reported to inhibit nucleotide excision repair in response 
to the DNA damage initiated by cisplatin (17).  DNA damage induced by UV or cisplatin 
is generally repaired by nucleotide excision repair mechanisms (18, 19).  These repair 
processes consist mainly of damage recognition, dual incision and excision of the 
oligomer including the damaged nucleotide, gap filling by DNA re-synthesis, and re-
joining by ligation (19, 20).  UCN-01 reduced the incision activity by inhibiting the 
interaction between the recognition protein XPA and endonuclease ERCC1 (17).  
In our previous studies, nucleotide excision repair was rapidly activated in 
quiescent normal lymphocytes or in CLL lymphocytes irradiated with UV or the 
cyclophosphamide prodrug 4-HC (21 - 23).  Concurrent treatment with a nucleoside 
analogue permitted its incorporation into the repair patch, inhibiting repair and resulting 
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in greater than additive cytotoxicity.  In the present study, we hypothesized that if UCN-
01 was combined with DNA damaging agents or modalities that induce DNA excision 
repair processes, UCN-01 would inhibit these repair processes, thereby enhancing 
cytotoxicity.  Thus, for the present study, normal and leukemic lymphocytes were 
stimulated to undergo DNA repair in vitro by UV or 4-HC.  DNA damage repair kinetics 
were evaluated by the alkaline single cell gel electrophoresis (comet) assay.  Both the 
formation of DNA single strand breaks resulting from incision and the subsequent 
rejoining event were inhibited by UCN-01 with an associated activation of apoptotic cell 
death processes. 
 
Materials and methods 
Chemicals and reagents.  UCN-01 (NSC 638850), 7-hydroxystaurosporine, 
was kindly provided by the Drug Synthesis and Chemistry Branch, Division of Cancer 
Treatment, National Cancer Institute (Bethesda, MD).  Aliquots of UCN-01 (10 mM in 
dimethyl sulfoxide) were stored at –20 °C and diluted in water immediately prior to each 
experiment.  The cyclophosphamide prodrug 4-HC was kindly provided by Dr. M. Colvin 
 - 8 - 
and Dr. S. Ludeman (Duke Univ., Durham, NC).  This compound is metabolized to 
phosphoramide mustard, an active bifunctional alkylator (24, 25). [methyl-1’, 2’-
3H]Thymidine (123 Ci/mmol) was purchased from Amersham Pharmacia Biotech 
(Piscataway, NJ).  FITC-conjugated annexin V was purchased from Becton Dickinson 
(San Jose, CA).  Hoechst No. 33342 was obtained from SIGMA (St. Louis, MO). 
Preparation of normal lymphocytes and CLL lymphocytes.  Normal 
lymphocytes from 6 healthy donors or leukemic lymphocytes from 16 patients with CLL 
that were not refractory to alkylating agents were used.  Whole blood was drawn into 
heparinized tubes, layered over Fico/Lite LymphoH (specific gravity, 1.077) (Atlanta 
Biologicals, Norcross, GA), and centrifuged at x 430 g for 20 min.  Lymphocytes were 
harvested from the interface, washed three times with fresh media, counted and sized 
using a Z2 Coulter particle counter and size analyzer (Coulter Corporation, Miami, FL).  
Then, the lymphocytes were resuspended at 1 x 106 cells/ml in RPMI 1640 
supplemented with 10% heat-inactivated fetal calf serum (Life Technologies, Inc., Grand 
Island, NY) and 2 mM L-glutamine, and incubated in a 5% CO2 humidified atmosphere 
at 37 °C overnight. 
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UV exposure and drug treatments.  Normal lymphocytes or CLL lymphocytes 
were pre-incubated with UCN-01 at indicated concentrations or not, followed by UV 
exposure or by an incubation with 4-HC.  For UV exposure, lymphocytes (2 x 106 cells) 
were irradiated with UV light (254 nm) from a UVGL-25 lamp (UVP, Inc., San Gabriel, 
CA) (21).  Radiation intensity was measured by UVX-25 UV meter (UVP, Inc.).  4-HC 
was added to the cell suspension (1 x 106 cells/ml) to give the final concentration of 60 
μM, and the incubation was performed for 30 min at 37 °C.  The lymphocytes treated 
under all conditions were immediately washed into fresh media, and then incubated for 
the indicated periods. 
Evaluation of DNA damage repair.  DNA damage and repair kinetics were 
determined as DNA single strand breaks with the use of the alkaline single cell gel 
electrophoresis (comet) assay as previously described (23).  Briefly, after the treatment 
lymphocytes were mixed with agarose and placed onto a microscope slide.  After 
solidification, the slides were left in lysis solution (2.5 M NaCl, 10 mM Tris, 100 mM 
ethylenediamine tetraacetic acid, 10% dimethylsulfoxide, and 1% Triton X-100, pH 10) for 
1 h at 4 °C.  The slides were then soaked in alkaline buffer (1 mM ethylenediamine 
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tetraacetic acid, and 300 mM NaOH, pH 13) for 20 min, and subjected to electrophoresis 
(35 V, 300 mA) for the next 20 min at 4 °C.  After the electrophoresis, the slides were 
neutralized and stained with ethidium bromide.  Cells, 100 per treatment condition, were 
analyzed by a computer-based image analysis system (Kinetic Imaging Komet system, 
Version 4.0, Liverpool, UK).  Cellular responses to DNA damage were quantitated and 
expressed as the “tail moment.”   
Evaluation of DNA resynthesis.  DNA resynthesis during the repair process 
was evaluated by assessing the incorporation of tritiated thymidine (21).  Normal 
lymphocytes (2 x 106 cells) having previously been treated and washed into fresh media 
were incubated with tritiated thymidine (specific activity was about 3 μCi/ml) for 0, 1, 2, 4 
and 6 h.  The lymphocytes were then collected, centrifuged, and resuspended in 500 μl 
of 0.4 N perchloric acid.  The sample was mixed, centrifuged, and resuspended again in 
perchloric acid.  After another mixing and centrifugation, the pellet was resuspended in 1 
ml of 0.5 N KOH and incubated at 45 °C overnight to dissolve the pellets.  Radioactivity 
was counted with a liquid scintillation counter (Packard Instrument Co.). 
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Quantitation of apoptotic cell death.  To evaluate cytotoxicity, apoptotic cell 
death was determined at 24 h after the treatments as phosphatidylserine externalization 
using annexin V staining (23) or by the nuclear morphology using Hoechst No. 33342 
staining (26).  For annexin V staining, lymphocytes were suspended in 200 µl of binding 
buffer (10 mM Hepes/NaOH, 140 mM NaCl, and 2.5 mM CaCl2) and 10 µl of FITC-
conjugated annexin V.  The sample was incubated for 15 min at room temperature and 
centrifuged again.  The pellet was resuspended with 500 µl of the same buffer and with 
10 µl of 50 µg/ml propidium iodide.  The sample was analysed with a FACScan flow 
cytometer (Becton Dickinson, San Jose, CA) using the CellQuest program (Becton 
Dickinson).  Cells positive for annexin V were considered apoptotic.  For Hoechst staining, 
cells were incubated with 2 μg/ml Hoechst No. 33342 for 30 min at 37 °C.  Nuclei, 200 
per treatment condition, were counted under UV illumination using the fluorescence 
microscope (LABOPHOTO-2, Nikon, Japan).  Apoptotic cell death was determined by the 
nuclear morphology with nuclear condensation and fragmentation. 
Statistical analysis.  All statistical analyses were performed with Microsoft 
Excel (Redmond, WA).  The extent of the incision response, the rate of repair, and 
 - 12 - 
cytotoxic effects were evaluated by the paired t tests with regard to the response due to 
UCN-01 and either 4-HC or UV, and that observed following the combinations.  All 
graphs, linear regression lines, and curves were generated with GraphPad, Prism 
software (GraphPad Software, Inc. San Diego, CA).   
Results 
The effect of UCN-01 on UV-induced DNA repair in normal lymphocytes.  
To evaluate the effect of UCN-01 on DNA repair, we first used UV as a DNA-damaging 
modality because it induces a well-characterized nucleotide excision repair response 
(27).  When normal lymphocytes were irradiated, the tail moment was greatest at 1 h 
after the exposure, suggesting the maximal DNA strand breaks resulting from the 
incision of the nucleotide excision repair (Fig. 1A).  The tail moment decreased promptly 
thereafter, suggesting that the damaged DNA was rapidly repaired and rejoined by 
ligation.  The tail-moment value came to the control level at 4 h after UV exposure, 
suggesting the completion of the repair process.  When the lymphocytes were pre-
incubated for 3 h with the escalating concentrations of UCN-01, the tail-moment values 
at 1 h were smaller and the subsequent tail moments at 4 h were greater than those 
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generated by UV alone (Fig. 1A).  The concentration-dependent decrease in the tail-
moment values at 1 h suggests some inhibition in the recognition or the incision step 
(Fig. 1B).  The tail-moment value at 1 h for UV alone was 5.2 ± 1.4 (mean ± SD), 
whereas the value for the combination with 300 nM UCN-01 was 3.6 ± 1.7, suggesting 
30% inhibition (P = 0.01 for paired samples).  The ratio of the tail moment at 1 h to 4 h 
was taken as an indication of the rate of repair (Fig. 1C).  This represents successful 
completion of processes enabling rejoining of the incised DNA.  This was also reduced 
by the escalating levels of UCN-01, and came down to 1 at 150-300 nM, indicating 
complete inhibition.  Intra-individual analyses indicated that the rate of repair at 300 nM 
UCN-01 was significantly less than that at 50 nM UCN-01 (P  = 0.01, paired t-test) 
The effect of UCN-01 on the DNA resynthesis step in normal lymphocytes.  
The incorporation of tritiated thymidine into DNA was quantitated to evaluate the action 
of UCN-01 on the DNA resynthesis step.  UV exposure initiated the incorporation of 
thymidine into DNA, and this incorporation appeared to reach a plateau at 4 h, 
suggesting the completion of the resynthesis step (Fig. 2).  Pre-treatment with UCN-01 
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significantly reduced DNA resynthesis at 6 h (P = 0.04 for paired samples).  The average 
inhibition reached 45% at 6 h.  
Enhancement of UV-induced cytotoxicity by UCN-01 in normal 
lymphocytes.  To evaluate the effect of UCN-01 on UV-induced loss of viability, the 
apoptotic cell death was determined by annexin V binding at 24 h after the cells had 
been treated with UV, or UCN-01, or both in combination.  The combination showed 
more than additive apoptotic cell death than the sum of each treatment alone (paired 
analysis, P = 0.04) (Fig. 3).  
The effect of UCN-01 on 4-HC-induced DNA repair in normal lymphocytes.  
Next, we used the prodrug of cyclophosphamide, 4-HC, as a DNA damaging agent, 
because cyclophosphamide is widely used in the treatment of various malignancies 
including indolent diseases such as CLL (24).  Unlike UV, 4-HC treatment of normal 
lymphocytes gave the highest tail-moment value at the end of the incubation period (Fig. 
4A).  This peak was followed by a rapid decrease after washing the cells into fresh 
media.  This suggests that 4-HC also initiated the DNA damage repair response in 
normal lymphocytes, and that the cells were capable of promptly initiating and rapidly 
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completing these processes.  When the cells were pre-incubated with escalating 
concentrations of UCN-01, the initial tail-moment values were smaller and the 
subsequent tail moments at 2 h were greater than those generated by 4-HC alone (Fig. 
4B).  The initial tail-moment value at 0 h decreased in a concentration-dependent 
manner, suggesting some inhibition in the recognition or the incision step (P = 0.05 for 
the paired analysis of 0 h-tail-moment values between 4-HC alone and the combination 
with 300 nM UCN-01) (Fig. 4C).  The rate of repair, as indicated by the ratio of the tail-
moment values at 0 h and 2 h, was also reduced by the escalating concentrations of 
UCN-01 (Fig. 4D). .  Intra-individual analyses indicated that the rate of repair at 300 nM 
UCN-01 was significantly less than that at 50 nM UCN-01 (P  = 0.04, paired t-test) 
Enhancement of 4-HC-induced cytotoxicity by UCN-01 in normal 
lymphocytes.  Apoptotic cell death was measured between 4 and 72 h to compare the 
cytotoxicity of 4-HC, UCN-01, or both in combination (Fig. 5).  None of the treatments 
induced significant apoptotic morphology in nuclei after 4 h.  Neither did UCN-01 alone 
cause cell death after as long as 72 h.   The combination treatment showed more than 
additive apoptotic cell death than the sum of each treatment alone at 24 h (paired 
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analysis, P = 0.04).  Although 4-HC alone caused apoptosis on average less than 10% 
of the cells at 24 h, this increased to >20% at later times, thereby masking the 
opportunity to evaluate the effects of the combination.  Thus it appears that the 
combination treatment accelerates the onset of cell death; hereafter, the 24-h time point 
was used for the evaluation of viability. 
Scheduling the combination of UCN-01 with 4-HC.  To evaluate scheduling 
the combination treatment with UCN-01 in relation to DNA repair initiated by 4-HC, 
normal lymphocytes were incubated with UCN-01 either before 4-HC treatment or at 
various times thereafter.  Tail moments were quantitated at 0 h and 2 h after the end of 
the incubation period with 4-HC.  The rate of repair, as indicated by the ratio of the tail 
moment at 0 h and 2 h, was reduced only when cells were exposed to UCN-01 prior to 
4-HC addition (Fig. 6A).  This finding suggests that repair was most effectively blocked 
when UCN-01 was present prior to DNA damage.  The subsequent cytotoxicity that was 
determined at 24 h after the treatments was enhanced only by the pre-treatment with 
UCN-01 (paired analyses, p = 0.04), suggesting that the inhibition of repair is important 
for the increased cytotoxicity (Fig. 6B).  
 - 17 - 
Effect of UCN-01 on 4-HC-induced repair in CLL lymphocytes.  Finally, to 
evaluate this combination strategy for CLL, lymphocytes from 16 patients with CLL were 
treated with 4-HC, UCN-01, or both in combination.  4-HC also initiated the DNA 
damage repair response in CLL lymphocytes, although there was heterogeneity among 
individuals (Fig. 7A).  The repair process seemed most linear and steepest between 0 h 
and 2 h, whereas the slope decreased after 2 h.  Thus, the time points of 0 h and 2 h 
were used for the subsequent comet analysis.  There was a concentration-dependent 
inhibition of these responses by UCN-01 (Fig. 7B).  The initial tail-moment values at 0 h 
were decreased by the escalating concentrations of UCN-01, suggesting some inhibition 
in the recognition or the incision step in CLL lymphocytes (P = 0.01 for the paired 
analysis of 0 h-tail-moment values between 4-HC alone and the combination with 300 
nM UCN-01) (Fig. 7C).  The rate of repair, indicated by the ratio of the tail-moment 
values at 0 h and 2 h, was completely inhibited (a value of 1) by 300 nM UCN-01, 
suggesting inhibition of processes required for completion of repair (Fig. 7D).  
Enhancement of 4-HC-induced cytotoxicity by UCN-01 in CLL 
lymphocytes.  To evaluate the effect of UCN-01 on 4-HC-induced cytotoxicity in CLL 
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lymphocytes, apoptotic cell death was determined at 24 h after the treatments.  The 
combination of 4-HC with 300 nM UCN-01 produced more than additive apoptotic cell 
death than the sum of each treatment alone (paired analyses, P = 0.01) (Fig. 8).  This 
was not the case at 50 or 150 nM, the concentrations that incompletely inhibited the 
repair (P = 0.8 and 0.2, respectively), suggesting that the extent of DNA repair inhibition 
was closely associated with the enhancement of the cytotoxicity.   
 
Discussion 
In growing cells, UCN-01 has been shown to have a variety of effects by inhibiting 
kinases that are involved in the cell cycle progression (2, 3) and checkpoint responses 
(15).  Our investigation was prompted by two recent reports.  One is the finding that 
nucleoside analogues can be incorporated into the DNA repair patch generated by 
excision repair processes, thereby inhibiting repair and enhancing cytotoxicity (21-23).  
Another stimulus was the report describing UCN-01 inhibition of nucleotide excision 
repair in response to the DNA damage initiated by cisplatin (17).  This inhibitory effect of 
UCN-01 was not related to the cell cycle progression that has been a major target for the 
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study of the activity in UCN-01.  Therefore, we have used quiescent lymphocytes to 
eliminate the influence of the cell cycle in order to focus on different actions of UCN-01 
in the context of DNA repair processes..  
UCN-01 inhibited DNA repair initiated by either UV or 4-HC in normal 
lymphocytes as well as CLL lymphocytes in a concentration-dependent manner. The 
inhibitory effects were demonstrated by the decrease in the initial formation of the tail 
moment, the inhibition of thymidine incorporation, and the reduction of the overall rate of 
repair.  These parameters are thought to reflect the incision around the lesion, DNA 
resynthesis, and the ligation steps of excision repair processes (22, 23, 28).  The 
cytotoxicity induced by UV or 4-HC in the presence of 300 nM UCN-01, the 
concentration that maximized repair inhibition, was greater than that predicted by 
additivity of the agents alone.  Thus, these findings extend prior studies (17) that 
demonstrated the inhibitory action of UCN-01 on nucleotide excision repair to 4-HC, an 
agent that induces multiple excision repair mechanisms.  
Damage to DNA caused by UV is comprised of cyclobutane dimers and 6-4-
photoproducts, which activate nucleotide excision repair processes (19, 20, 27, 29).  In 
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contrast, alkylation with agents such as 4-HC has been shown to induce base excision 
repair and cross-link repair as well (18, 30, 31).  In the present study, UV induced a 
significant increase in a tail-moment value at 1 h after the exposure (Fig. 1), whereas the 
cellular response to 4-HC was maximal at the end of the 30-min incubation (Fig. 4).  As 
this initial elevation represents the recognition and subsequent incision steps in the 
repair processes, the results are consistent with the interpretation that 4-HC generates 
responses earlier than UV by activating multiple mechanisms of recognition and incision 
detected by the comet assay.  The subsequent gap filling by DNA resynthesis following 
irradiation was demonstrated by the incorporation of tritiated thymidine into DNA (Fig. 2).  
This increased time-dependently and reached a plateau at 4 h, suggesting the 
completion of this step.  This behavior might be associated with the decrease in the tail-
moment values in later times.  After the initial increase, the tail-moment values declined 
with time, decreasing to the control level at 4 h after UV exposure.  This diminution of 
the tail-moment values represents the disappearance of the DNA single strand breaks 
that had been incised in the initial steps of the repair processes.  Therefore, the rate of 
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repair, the ratio of the tail-moment values at 1 h to those at 4 h, would represent the sum 
of processes leading to the rejoining of the DNA strands. 
UCN-01 at 300 nM maximally inhibited DNA repair initiated by both UV and 4-HC, 
and enhanced the cytotoxicity in both normal and CLL lymphocytes (Figs. 3, 5, & 8).  
The inhibition of the repair by the higher concentration (300 nM) of UCN-01 was 
significantly greater than that cause by the lower concentration (50 nM).  Lesser 
concentrations of UCN-01 that incompletely inhibited repair did not show greater than 
additive cell killing (Figs. 7 & 8).  The actions of UCN-01 were also schedule-dependent, 
as the lymphocytes treated with UCN-01 after completion of the repair processes neither 
formed comets nor did cells become annexin positive (Figure 6).  These findings 
suggest that the inhibition of repair would be closely associated with the enhancement of 
cytotoxicity.  Moreover, annexin-positive lymphocytes at 4 h after the treatment were 
less than 10%, indicating no increased loss of viability (Figure 5).  Therefore, we 
speculate that the inhibition of the repair would be attributed to the specific effect of 
UCN-01, not to an immediate cytotoxic  action of the compound, which has been 
observed only at considerably greater concentrations after durations of days (32, 33).   
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Investigations of the signaling pathways that are activated by inhibition of DNA repair 
processes have been initiated (34).  A recent phase I trial of UCN-01 by 72-h continuous 
infusion indicated that a maximum tolerated dose of 42.5 mg/m2/day for 3 days achieved 
the free drug concentration at 111 nM, measured as a salivary concentration as a 
reflection of plasma levels (16).  A second phase I investigation using a 3-hr i.v. infusion 
of 51.1 mg/m2 demonstrated free UCN-01 in plasma to exceed 400 nM4.  This suggests 
that with infusion schedule modifications, the UCN-01 concentrations inhibitory to DNA 
repair used in the present study may be clinically achievable.  Moreover, the elimination 
half-life of the plasma UCN-01 concentration was extremely long with the median value 
of 26 days (16).  This indicates that an inhibitory action on DNA repair by UCN-01 could 
be effective for a prolonged duration, and in fact this might extend to a subsequent 
course of therapy. 
With regard to scheduling relative to induction of DNA repair, only pre-treatment 
with UCN-01 inhibited 4-HC-induced DNA repair and enhanced the cytotoxicity (Fig. 6).  
This is similar to the requirements for cytotoxicity observed when 4-HC-induced repair in 
CLL lymphocytes was inhibited by the nucleoside analogues fludarabine and clofarabine 
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(23).  Apparently, both normal and leukemic lymphocytes are primed with excision repair 
processes to respond to DNA damage.  This immediate response capability 
necessitates, however, the presence of the repair inhibitor in cells at the time of damage 
to maximize the consequences of this mechanism-based interaction.  Although UCN-01 
alone is clearly toxic to CLL lymphocytes, the greater concentrations and longer duration 
of incubations required for these actions suggest a different mechanism of action (32, 
33).  
The precise target(s) of UCN-01 in the DNA excision repair processes remain to 
be elucidated.  The report of Yang et al (17) demonstrated that UCN-01 inhibited the 
interaction of XPA and ERCC1 and reduced the incision activity in assays of nucleotide 
excision repair. This  cannot fully explain the actions of UCN-01 on DNA repair 
demonstrated in the present study, as clearly the processes of repair that occur 
subsequent to incision are also affected.  Prior investigations have demonstrated that 
UCN-01 inhibits the phosphotransferase activity of multiple kinases (1, 15, 35, 36).  Most 
likely, this is due to UCN-01 blocking access of ATP to its binding site on the enzymes.  
In this context, several proteins involved in nucleotide excision repair exhibit kinase 
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activity, and therefore might be considered as potential targets for UCN-01.  For 
instance, replication protein A becomes hyperphosphorylated in response to DNA 
damage induced by UV (37 - 39).  Gap filling and ligation is mediated via an interaction 
between proliferating cell nuclear antigen and replication factor C.  Proliferating cell 
nuclear antigen interacts with cyclin-dependent kinase 2 and cyclin A, which target 
replication factor C and DNA ligase I for phosphorylation (40 – 42).  Cyclin-dependent 
kinase 1 and 2 might be dysregulated through the inhibition of Chk1 by UCN-01 (2, 3, 
43).  The biological significance of the inhibition of such phosphorylation reactions is not 
completely understood.  However, some of the DNA repair proteins must be in the 
proper phosphorylation states for the optimal efficiency of the excision repair (20).  Thus, 
it is suggested that a protein kinase inhibitor such as UCN-01 might interfere 
phosphorylation of repair enzymes, resulting in the inhibition of the repair, although this 
remains to be determined. 
In conclusion, UCN-01 has shown several effects on the cell cycle, which would 
address the use of this drug in combination strategies for cancer treatment in terms of 
the cycling cells.  The present study demonstrated that UCN-01 inhibited DNA repair, 
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thereby enhancing the cytotoxicity of DNA damage-inducing agents in quiescent cells.  
Our findings suggest that UCN-01 would be a good candidate for combination strategies 
in slow-growing tumors such as CLL. 
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Figure Legends 
Fig. 1 Effect of UCN-01 on UV-induced DNA repair in normal lymphocytes.  Normal 
lymphocytes from 6 healthy donors were pre-incubated for 3 h with UCN-01 at 50, 150, 
or 300 nM, or not, followed by 4 J/m2 UV exposure and immediate washing the cells into 
fresh media.  Tail moments were determined at 0, 0.5, 1, 2, and 4 h.  (A) Time course of 
DNA repair.  (•); UV alone, (o); 50 nM UCN-01, (Υ); 150 nM UCN-01, (∆); 300 nM UCN-
01.  The tail-moment value of untreated cells was set as a control (hair line).  (B) The 
tail-moment values at 1 h (mean ± SD).  (C) The rate of repair indicated by the ratio of 
the tail-moment values at 1 h and 4 h (mean ± SD). 
 
Fig. 2 The effect of UCN-01 on DNA resynthesis step in normal lymphocytes.  Normal 
lymphocytes from 6 healthy donors were pre-incubated for 3 h with 300 nM UCN-01 (o) 
or not (•), followed by 4 J/m2 UV exposure.  After washing the samples into fresh media, 
the lymphocytes were incubated with tritiated thymidine for 0, 1, 2, 4, and 6 h (mean ± 
SD).   
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Fig. 3 Enhancement of UV-induced cytotoxicity by UCN-01 in normal lymphocytes.  
Normal lymphocytes from 6 healthy donors were treated with a 3-h incubation with 300 
nM UCN-01, or 4 J/m2 UV exposure, or a 3-h pre-incubation with 300 nM UCN-01 
followed by 4 J/m2 UV exposure.  At 24 h after the treatments, the apoptotic cell death 
was measured by annexin V binding (mean ± SD). 
 
Fig. 4 Effect of UCN-01 on 4-HC-induced DNA repair in normal lymphocytes.  Normal 
lymphocytes from 6 healthy donors were incubated for 3 h with UCN-01 at 50, 150, and 
300 nM, or not, with a co- incubation with 60 μM 4-HC for the last 30 min.  Tail moments 
were determined at 0, 0.5, 1, 2, and 4 h after washing the samples into fresh media.  (A) 
Time course of DNA repair initiated by 4-HC.  The tail-moment value of untreated cells 
was set as a control (hair line).  (B) Tail moments at 0 h and 2 h.  (•); 4-HC alone, (o); 50 
nM UCN-01, (Υ); 150 nM UCN-01, (∆); 300 nM UCN-01.  (C) The tail-moment values at 
0 h (mean ± SD).  (D) The rate of repair indicated by the ratio of the tail-moment values 
at 0 h and 2 h (mean ± SD). 
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Fig. 5 Enhancement of 4-HC-induced cytotoxicity by UCN-01 in normal lymphocytes.  
Normal lymphocytes from 6 healthy donors were treated with a 3-h incubation with 300 
nM UCN-01, or a 30-min incubation with 60 μM 4-HC, or both in combination. Apoptotic 
cell death was measured by the nuclear morphology using Hoechst No. 33342 staining 
(mean ± SD) at 4 h, 24 h, 48 h, and 72 h after the treatment. 
 
Fig. 6 Scheduling the combination of UCN-01 with 4-HC.  Normal lymphocytes from 3 
healthy donors were incubated with 300 nM UCN-01 either before a 30-min incubation 
with 60 μM 4-HC or at various times (0, 1, and 2 h) thereafter.  (A) Tail moments were 
quantitated at 0 h and 2 h after the end of the incubation period with 4-HC (mean ± SD).  
The rate of repair, indicated by the ratio of the tail-moment values at 0 h and 2 h, was 
also determined.  (B) The subsequent cytotoxicity was determined at 24 h after the 
treatments by annexin V binding (mean ± SD).  Treatments; (1), 4-HC alone, (2), UCN-
01→4-HC, (3), 4-HC→0 h→UCN-01, (4), 4-HC→1 h→UCN-01, (5), 4-HC→2 h→UCN-
01.  (6), UCN-01 alone,   
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Fig. 7 Effect of UCN-01 on 4-HC-induced DNA repair in CLL lymphocytes.  CLL 
lymphocytes from 16 patients were incubated for 3 h with UCN-01 at 50, 150, and 300 
nM, or not, with a co-incubation with 60 μM 4-HC for the last 30 min.  Tail moments were 
determined at 0, 0.5, 1, 2, and 4 h after washing the samples into fresh media.  (A) Time 
course of DNA repair initiated by 4-HC (mean ± SD).  The tail-moment value of 
untreated cells was set as a control (hair line).  (B) Effect of UCN-01 on 4-HC-induced 
DNA repair.  Tail moments at 0 h and 2 h.  (•); 4-HC alone, (o); 50 nM UCN-01, (Υ); 150 
nM UCN-01, (∆); 300 nM UCN-01.  (C) The tail-moment values at 0 h (mean ± SD).  (D) 
The rate of repair indicated by the ratio of the tail-moment values at 0 h and 2 h (mean ± 
SD).   
 
Fig. 8 Enhancement of 4-HC-induced cytotoxicity by UCN-01 in CLL lymphocytes.  CLL 
lymphocytes from 16 patients were treated with a 3-h incubation with 300 nM UCN-01, 
or a 30-min incubation with 60 μM 4-HC, or both in combination.  At 24 h after the 
treatments, apoptotic cell death was measured by annexin V binding (mean ± SD).   
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